What is AKYNZEO 300 mg/0,5 mg, gélules used for?

( ARTG ) AKYNZEO is indicated in adult patients for: Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

What are the side effects of AKYNZEO 300 mg/0,5 mg, gélules?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can AKYNZEO 300 mg/0,5 mg, gélules be used during pregnancy?

( AHT ) For the active ingredient netupitant + palonosetron You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures AKYNZEO 300 mg/0,5 mg, gélules?

HELSINN BIREX PHARMACEUTICALS (FR)

OTC

AKYNZEO 300 mg/0,5 mg, gélules

INN: NÉTUPITANT

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇫🇷

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

HELSINN BIREX PHARMACEUTICALS

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.